Hexagon Nutrition Limited has officially announced the launch of its much-awaited Initial Public Offering (IPO), which will open for public subscription on June 5, 2026, and close on June 9, 2026. The company plans to raise approximately ₹138.87 crore through a book-built public issue consisting entirely of an Offer for Sale (OFS) of more than 3.08 crore equity shares. The shares are proposed to be listed on both the BSE and NSE, with the tentative listing date fixed for June 12, 2026.
The IPO price band has been fixed between ₹42 and ₹45 per equity share. Retail investors can apply for a minimum lot size of 333 shares, requiring an investment of approximately ₹14,985 at the upper price band. The anchor investor bidding process is scheduled to begin on June 4, one day before the issue opens for public subscription.
Founded in 1993, Hexagon Nutrition operates in the nutrition, wellness, and healthcare segment and is considered one of India’s established nutrition product manufacturers. The company focuses on three major business verticals — micronutrient premix products, clinical nutrition, and therapeutic nutrition solutions. Its product portfolio includes health supplements, pediatric nutrition products, obesity management supplements, protein nutrition products, and specialized medical nutrition formulations.
The company markets several consumer healthcare brands including Pentasure, Obesigo, Pediagold, and Nutrone. Industry experts believe increasing consumer awareness regarding preventive healthcare, protein supplementation, immunity products, and therapeutic nutrition has significantly boosted growth opportunities for nutrition-focused companies in India.
Hexagon Nutrition currently operates manufacturing facilities at Nasik, Chennai, and Thoothukudi in India, along with an international production facility in Tashkent, Uzbekistan. The company exports products to more than 75 countries across Asia, Africa, Europe, and South America. Market observers noted that the company’s diversified international presence and export network provide access to growing global nutrition and wellness markets.
Financially, the company has reported steady improvement in business performance over the last three financial years. According to the latest disclosed figures, Hexagon Nutrition reported revenue of approximately ₹331.29 crore in FY2025 compared with ₹304.62 crore in FY2024. Net profit also nearly doubled to ₹24.38 crore from ₹12.21 crore during the same period. Analysts stated that rising profitability and stable revenue growth have strengthened investor interest ahead of the IPO launch.
The company has also disclosed key financial performance indicators ahead of the issue. Hexagon Nutrition reported Return on Equity (ROE) of around 10.47%, Return on Capital Employed (ROCE) near 17.06%, EBITDA margin above 12%, and a relatively low debt-to-equity ratio of 0.14. Market experts believe the comparatively lower debt burden improves financial stability and operational flexibility.
Unlike many recent IPOs, the Hexagon Nutrition issue is entirely an Offer for Sale (OFS), meaning the company itself will not directly receive any proceeds from the IPO. Instead, the proceeds will go to existing selling shareholders. According to the Red Herring Prospectus (RHP), the company’s primary objectives include securing the benefits of stock exchange listing, enhancing brand visibility, improving market recognition, and providing liquidity opportunities to existing shareholders.
Grey market activity around the IPO has remained mixed ahead of subscription opening. Some market tracking platforms reported that the Grey Market Premium (GMP) currently remains flat or near zero, suggesting cautious investor sentiment before actual subscription data emerges. However, certain market reports indicated that unofficial grey market trends could still improve if institutional demand strengthens during the bidding period.
Industry analysts believe Hexagon Nutrition may benefit from strong long-term trends within India’s healthcare and nutrition industry. Rising lifestyle-related health concerns, increasing healthcare spending, growth in preventive nutrition products, and expanding demand for clinical dietary supplements are expected to drive long-term market growth. India’s nutrition and wellness industry has witnessed significant expansion as consumers increasingly focus on immunity, protein intake, child nutrition, and disease management solutions.
At the same time, market observers have highlighted certain risks associated with the company. Competition from established pharmaceutical and wellness brands, dependence on raw material pricing, regulatory compliance requirements, and fluctuations in export demand remain important operational challenges. Analysts also noted that because the IPO is entirely an OFS, no fresh capital will directly enter the company for expansion or debt reduction purposes.
The IPO comes during a renewed phase of activity in India’s primary market after a temporary slowdown caused by market volatility and geopolitical uncertainty. Alongside CMR Green Technologies, Hexagon Nutrition is among the key mainboard IPOs reviving investor participation in June 2026. Investors will now closely monitor subscription figures, institutional demand, and grey market trends once bidding officially begins on June 5.
Loading comments...